IMCR.NASDAQImmunocore Holdings PLC

SCHEDULE: PRIMECAP Boosts Immunocore Stake to 7.51%

Sentiment:

Beneficial Ownership Report

📋All filings for Immunocore Holdings PLC
🔒Login to Follow

PRIMECAP Management Co. reports an increased beneficial ownership of 7.51% in Immunocore Holdings plc ADRs.

Summary

  • PRIMECAP Management Co./CA/ filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Immunocore Holdings plc ADR.
  • As of the event date of June 30, 2025, PRIMECAP Management Co. beneficially owns 3,772,234 shares of Immunocore Holdings plc ADRs.
  • This ownership represents 7.51% of the class of securities.
  • PRIMECAP Management Co. holds sole voting power over 3,746,574 shares and sole dispositive power over 3,772,234 shares.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant and increased institutional investment in Immunocore Holdings plc, suggesting confidence from a major asset manager. While not a performance report, it reflects positive investor sentiment.

Positives

  • A significant institutional investor, PRIMECAP Management Co., holds a substantial 7.51% stake, indicating confidence in Immunocore Holdings plc.
  • The filing is an amendment, suggesting an ongoing or increased commitment from a major asset manager.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may view the increased institutional ownership as a positive signal of confidence in the company's prospects from a sophisticated investor.

Key Dates

DateDescription
06/30/2025Date of event which requires filing of this statement
08/14/2025Signature date of the filing by Jorge A. Rodriguez, Deputy Chief Compliance Officer

Recommendation

hold

The filing indicates a significant and increased stake by a major institutional investor, PRIMECAP Management Co., in Immunocore Holdings plc. While this signals confidence from a respected asset manager, the filing itself does not provide operational or financial performance data to warrant a stronger recommendation. It primarily serves as a disclosure of beneficial ownership.

Keywords

Immunocore Holdings plc, PRIMECAP Management Co., Beneficial Ownership, SEC Filing, Schedule 13G, ADR, Institutional Investment, Ownership Disclosure

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.